These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16442660)

  • 21. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes.
    Goodarzi MT; Navidi AA; Rezaei M; Babahmadi-Rezaei H
    J Clin Lab Anal; 2010; 24(2):72-6. PubMed ID: 20333759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of blood glucose and HbA(1c) goals on glycaemic control in children and adolescents with Type 1 diabetes.
    Boot M; Volkening LK; Butler DA; Laffel LM
    Diabet Med; 2013 Mar; 30(3):333-7. PubMed ID: 23190135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications.
    Vanizor B; Orem A; Karahan SC; Kiran E; Erem C; Aliyazicioğlu R; Uydu HA
    Diabetes Res Clin Pract; 2001 Oct; 54(1):33-9. PubMed ID: 11532328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
    Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
    Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus.
    Jain A; Saxena S; Khanna VK; Shukla RK; Meyer CH
    Mol Vis; 2013; 19():1760-8. PubMed ID: 23922493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.
    Stephens JW; Bodvarsdottir TB; Wareham K; Prior SL; Bracken RM; Lowe GD; Rumley A; Dunseath G; Luzio S; Deacon CF; Holst JJ; Bain SC
    Diabetes Res Clin Pract; 2011 Nov; 94(2):199-206. PubMed ID: 21835486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HbA(1c) levels in cardiovascular diseased patients without diabetes in a developing country.
    Sharma TK; Parchwani H; Kaushik GG; Shankar V; Dahiya K; Ghalaut VS; Sharma N
    Clin Lab; 2011; 57(7-8):517-22. PubMed ID: 21888015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative markers in diabetic ketoacidosis.
    Vantyghem MC; Balduyck M; Zerimech F; Martin A; Douillard C; Bans S; Degand PM; Lefebvre J
    J Endocrinol Invest; 2000 Dec; 23(11):732-6. PubMed ID: 11194706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rise and fall of HbA(1c) as a risk marker for diabetes complications.
    Kilpatrick ES
    Diabetologia; 2012 Aug; 55(8):2089-91. PubMed ID: 22711013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of glycaemic control on the vascular nitric oxide system in patients with type 1 diabetes.
    Rodríguez-Mañas L; López-Dóriga P; Petidier R; Neira M; Solís J; Pavón I; Peiró C; Sánchez-Ferrer CF
    J Hypertens; 2003 Jun; 21(6):1137-43. PubMed ID: 12777950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients.
    Jain SK; McVie R; Meachum ZD; Smith T
    Atherosclerosis; 2000 Mar; 149(1):69-73. PubMed ID: 10704616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress.
    Ceriello A; Falleti E; Bortolotti N; Motz E; Cavarape A; Russo A; Gonano F; Bartoli E
    Metabolism; 1996 Apr; 45(4):498-501. PubMed ID: 8609838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of structure, process, and policy on HbA(1c) levels in treatment of children and adolescents with type 1 diabetes.
    Hanberger L; Samuelsson U; Berterö C; Ludvigsson J
    Diabetes Res Clin Pract; 2012 Jun; 96(3):331-8. PubMed ID: 22326692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessing the increased glycation of hemoglobin in nondiabetic chronic renal failure patients: a hypothesis on the role of lipid peroxides.
    Selvaraj N; Bobby Z; Koner BC; Das AK
    Clin Chim Acta; 2005 Oct; 360(1-2):108-13. PubMed ID: 15979601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of ICAM-1 and circulating endothelial cells are elevated in unstable types 1 and 2 diabetes.
    El Amine M; Sohawon S; Lagneau L; Gaham N; Noordally S
    Endocr Regul; 2010 Jan; 44(1):17-24. PubMed ID: 20151764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect effects of decompression surgery on glycemic homeostasis in patients with type 2 diabetes mellitus and lumbar spinal stenosis.
    Kim HJ; Lee KW; Cho HG; Kang KT; Chang BS; Lee CK; Yeom JS
    Spine J; 2015 Jan; 15(1):25-33. PubMed ID: 24983668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of serum sialic acid with cardiovascular metabolic risk factors in Kuwaiti children and adolescents with type 1 diabetes.
    Moussa MA; Alsaeid M; Refai TM; Abdella N; Al-Sheikh N; Gomez JE
    Metabolism; 2004 May; 53(5):638-43. PubMed ID: 15131770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.